CL2010000743A1 - Compuestos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents
Compuestos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.Info
- Publication number
- CL2010000743A1 CL2010000743A1 CL2010000743A CL2010000743A CL2010000743A1 CL 2010000743 A1 CL2010000743 A1 CL 2010000743A1 CL 2010000743 A CL2010000743 A CL 2010000743A CL 2010000743 A CL2010000743 A CL 2010000743A CL 2010000743 A1 CL2010000743 A1 CL 2010000743A1
- Authority
- CL
- Chile
- Prior art keywords
- chromine
- contain
- pharmaceutical compositions
- preparation process
- derivative compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuestos derivados de crómeno; procedimiento de preparación; composición farmacéutica; y su uso para tratar enfermedades tales como esquizofrenia, psicosis, depresión, entre otras.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0903572A FR2948372B1 (fr) | 2009-07-21 | 2009-07-21 | Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2010000743A1 true CL2010000743A1 (es) | 2011-07-08 |
Family
ID=41856518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2010000743A CL2010000743A1 (es) | 2009-07-21 | 2010-07-12 | Compuestos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Country Status (27)
Country | Link |
---|---|
US (1) | US8247441B2 (es) |
EP (1) | EP2277882A1 (es) |
JP (1) | JP2011026319A (es) |
KR (1) | KR20110009064A (es) |
CN (1) | CN101962384B (es) |
AR (1) | AR077492A1 (es) |
AU (1) | AU2010202876A1 (es) |
BR (1) | BRPI1002409A2 (es) |
CA (1) | CA2709341A1 (es) |
CL (1) | CL2010000743A1 (es) |
CO (1) | CO6280049A1 (es) |
CR (1) | CR11566A (es) |
CU (1) | CU20100149A7 (es) |
EA (1) | EA017774B1 (es) |
EC (1) | ECSP10010357A (es) |
FR (1) | FR2948372B1 (es) |
GE (1) | GEP20125545B (es) |
IL (1) | IL206885A0 (es) |
MA (1) | MA32342B1 (es) |
MX (1) | MX2010007799A (es) |
NZ (1) | NZ586855A (es) |
PE (1) | PE20110156A1 (es) |
SG (1) | SG168482A1 (es) |
TW (1) | TW201109337A (es) |
UY (1) | UY32768A (es) |
WO (1) | WO2011010014A1 (es) |
ZA (1) | ZA201005203B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3495363B1 (en) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect |
JP7250405B2 (ja) | 2018-01-26 | 2023-04-03 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する環式化合物 |
CN111801330B (zh) | 2018-01-26 | 2024-04-05 | 盐野义制药株式会社 | 具有多巴胺d3受体拮抗作用的稠环化合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2722194B1 (fr) * | 1994-07-06 | 1996-08-23 | Adir | Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent |
AU5272296A (en) * | 1995-04-06 | 1996-10-23 | Novo Nordisk A/S | Benzopyranopyrrole compounds, their preparation and use |
FR2764890B1 (fr) * | 1997-06-24 | 1999-08-27 | Adir | Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
-
2009
- 2009-07-21 FR FR0903572A patent/FR2948372B1/fr not_active Expired - Fee Related
-
2010
- 2010-07-06 PE PE2010000440A patent/PE20110156A1/es not_active Application Discontinuation
- 2010-07-07 AU AU2010202876A patent/AU2010202876A1/en not_active Abandoned
- 2010-07-07 UY UY0001032768A patent/UY32768A/es unknown
- 2010-07-08 SG SG201004962-5A patent/SG168482A1/en unknown
- 2010-07-08 IL IL206885A patent/IL206885A0/en unknown
- 2010-07-12 CL CL2010000743A patent/CL2010000743A1/es unknown
- 2010-07-13 CR CR11566A patent/CR11566A/es not_active Application Discontinuation
- 2010-07-16 CO CO10087224A patent/CO6280049A1/es active IP Right Grant
- 2010-07-16 CU CU20100149A patent/CU20100149A7/es unknown
- 2010-07-16 GE GEAP201011892A patent/GEP20125545B/en unknown
- 2010-07-16 CA CA2709341A patent/CA2709341A1/fr not_active Abandoned
- 2010-07-16 NZ NZ586855A patent/NZ586855A/en not_active IP Right Cessation
- 2010-07-16 MX MX2010007799A patent/MX2010007799A/es unknown
- 2010-07-19 MA MA33038A patent/MA32342B1/fr unknown
- 2010-07-20 EP EP10290411A patent/EP2277882A1/fr not_active Withdrawn
- 2010-07-20 AR ARP100102637A patent/AR077492A1/es unknown
- 2010-07-20 WO PCT/FR2010/000519 patent/WO2011010014A1/fr active Application Filing
- 2010-07-20 BR BRPI1002409-3A patent/BRPI1002409A2/pt not_active Application Discontinuation
- 2010-07-20 JP JP2010162384A patent/JP2011026319A/ja not_active Ceased
- 2010-07-20 TW TW099123875A patent/TW201109337A/zh unknown
- 2010-07-20 US US12/804,355 patent/US8247441B2/en not_active Expired - Fee Related
- 2010-07-20 EC EC2010010357A patent/ECSP10010357A/es unknown
- 2010-07-20 EA EA201001041A patent/EA017774B1/ru not_active IP Right Cessation
- 2010-07-21 KR KR1020100070584A patent/KR20110009064A/ko not_active Application Discontinuation
- 2010-07-21 CN CN2010102347598A patent/CN101962384B/zh not_active Expired - Fee Related
- 2010-07-21 ZA ZA2010/05203A patent/ZA201005203B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI1002409A2 (pt) | 2012-05-15 |
WO2011010014A1 (fr) | 2011-01-27 |
PE20110156A1 (es) | 2011-03-19 |
MA32342B1 (fr) | 2011-06-01 |
GEP20125545B (en) | 2012-05-25 |
FR2948372B1 (fr) | 2011-07-22 |
EA201001041A1 (ru) | 2011-02-28 |
CO6280049A1 (es) | 2011-05-20 |
ZA201005203B (en) | 2011-03-30 |
EA017774B1 (ru) | 2013-03-29 |
TW201109337A (en) | 2011-03-16 |
FR2948372A1 (fr) | 2011-01-28 |
CU20100149A7 (es) | 2012-03-15 |
CN101962384B (zh) | 2013-04-10 |
CN101962384A (zh) | 2011-02-02 |
UY32768A (es) | 2011-01-31 |
SG168482A1 (en) | 2011-02-28 |
EP2277882A1 (fr) | 2011-01-26 |
CR11566A (es) | 2010-09-13 |
JP2011026319A (ja) | 2011-02-10 |
US20110021490A1 (en) | 2011-01-27 |
AU2010202876A1 (en) | 2011-02-10 |
NZ586855A (en) | 2011-11-25 |
MX2010007799A (es) | 2011-02-03 |
CA2709341A1 (fr) | 2011-01-21 |
IL206885A0 (en) | 2010-12-30 |
ECSP10010357A (es) | 2011-02-28 |
AR077492A1 (es) | 2011-08-31 |
KR20110009064A (ko) | 2011-01-27 |
US8247441B2 (en) | 2012-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017002650A1 (es) | Compuestos novedosos | |
ECSP11011517A (es) | Compuestos antivirales | |
GT201400111A (es) | Triazolopiridinas sustituidas | |
SV2011003855A (es) | Heteroarilos sustituidos | |
UY33735A (es) | Compuestos antivirales | |
ECSP14017269A (es) | Compuestos para tratar la atrofia muscular espinal | |
GT201000023A (es) | Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met. | |
CL2014001752A1 (es) | Compuestos biciclicos sustituidos; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades tales como cancer, alzheimer, sida, entre otras. | |
CO6670575A2 (es) | Aminopirazoloqinazolinas sustituidas, útiles en el tratamiento de enfermedades proliferativas y composiciones farmaceúticas que las continen | |
NI201400070A (es) | Compuestos de benzaldehído sustituidos y métodos para su uso en incrementar la oxigenación del tejido. | |
CR20130560A (es) | Compuestos de bezotiazol y su uso farmacéutico | |
UY32728A (es) | Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia | |
DOP2015000054A (es) | Derivados de c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso | |
ECSP11011470A (es) | Nuevos derivados de pirimidina y sus usos en el tratamiento del cáncer y otras enfermedades | |
CL2014001174A1 (es) | Compuestos derivados de [1,2,3]triazolo[4,5-d]pirimidina y sus sales, como agonistas del receptor de canabinoides 2; su proceso de obtencion; composicion farmaceutica que los contiene; y su uso para el tratamiento o profilaxis del dolor, aterosclerosis, inflamacion, glaucoma, ataque isquemico transitorio, entre otras enfermedades. | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
CL2010001637A1 (es) | Compuestos derivados de isoindolonas; composición farmacéutica que los comprende; y su uso como inhibidores de la quinasa mek para tratar enfermedades hiperproliferativas y/o inflamatorias tales como cáncer, artritis reumatoidea entre otras. | |
UY32937A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119 | |
UY32387A (es) | Ciclopentanodionas herbicidamente activas, derivados, procesos para su preparación, composiciones que las comprenden y usos de las mismas | |
GT201400090A (es) | 2-tiopirimidinonas | |
CL2018001210A1 (es) | Compuestos de criptoficina novedosos y productos conjugados, su preparación y su uso terapéutico. | |
CL2011002258A1 (es) | Compuestos derivados heterociclicos fusionados; composicion farmaceutica que los comprende; y uso de los compuestos para tratar vih. | |
CL2011002617A1 (es) | Compuestos derivados de arilsulfonamidas 2,5-disustituidas, moduladores del receptor ccr3; composicion farmaceutica que los comprende; y uso del compuesto o de la composicion para prevenir y/o tratar un trastorno inflamatorio o inmunoregulador tal como asma, rinitis, vih, enfermedad de alzheimer, entre otros. | |
CL2011000865A1 (es) | Compuestos derivados de isoquinolinona; composicion farmaceutica que los comprende; y uso del compuesto para tratar enfermedades tales como psicosis, esquizofrenia, alzheimer entre otras. | |
CO6321288A2 (es) | Sales de compuestos inhibidores de vih |